CNVY SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Convey Health Solutions Holdings, Inc. and Encourages Current Stockholders to Contact the Firm
PHILADELPHIA, June 21, 2022 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Convey Health Solutions Holdings, Inc. (“Convey Health”) (NYSE: CNVY) on behalf of the company’s current stockholders.
On June 18, 2021, Convey Health completed its initial public offering (“IPO”) of common stock, selling over 11.6 million shares of stock to investors at a price of $14.00 per share. By May 2022, shares of Convey Health’s stock had declined in value to approximately $5.00 per share.
On June 21, 2022, Convey Health announced that it had agreed to be acquired by private equity firm TPG at a price of $10.50 per share. Following the closing of the proposed transaction, shares of Convey Health’s stock will no longer be publicly traded.
The investigation seeks to determine whether the members of Convey Health’s Board of Directors violated the securities laws or breached their fiduciary duties by failing to maximize the buyout price for CNVY investors, and whether Convey Health shareholders are being provided with all material information about the proposed transaction.
*Convey Health shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (**firstname.lastname@example.org**) or online at **https://kaskelalaw.com/cases/convey-health/**, for additional information about this investigation and their legal rights and options.*
Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
*KASKELA LAW LLC*
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
(888) 715 – 1740